Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,253 | -14,323 | -10,667 | -7,201 | -3,365 |
| Depreciation Amortization | 0 | 2 | 2 | 1 | 1 |
| Other Working Capital | -1,307 | -1,580 | -2,490 | -778 | -560 |
| Other Operating Activity | 598 | 2,823 | 2,288 | 1,711 | 807 |
| Operating Cash Flow | $-4,962 | $-13,078 | $-10,867 | $-6,266 | $-3,118 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,141 | -16,600 | -21,719 | -18,780 | -2,971 |
| Other Investing Activity | 0 | 173 | 173 | 173 | 173 |
| Investing Cash Flow | $2,141 | $-16,427 | $-21,547 | $-18,608 | $-2,798 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 9,627 | 39,132 | 39,132 | 39,132 | 39,132 |
| End Cash Position | 6,805 | 9,627 | 6,718 | 14,259 | 33,216 |
| Net Cash Flow | $-2,822 | $-29,505 | $-32,414 | $-24,873 | $-5,916 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,962 | -13,078 | -10,867 | -6,266 | -3,118 |
| Free Cash Flow | -4,962 | -13,078 | -10,867 | -6,266 | -3,118 |